Silencing fatty acid binding protein 5 inhibits prostaglandin E2 and activates CD8 T cells in castration-resistant prostate cancer
Reproductive Biology · 2026-06 · 26 (2) · 101187
DOI: 10.1016/j.repbio.2026.101187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive Biology, 2026-06. Verfasst von Jun Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China. Electronic address: Songjun2812@163.com. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Dinoprostone, Fatty Acid-Binding Proteins, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Prostate cancer (PCa) frequently progresses to incurable castration-resistant prostate cancer (CRPC) following androgen deprivation therapy. The immunosuppressive tumor microenvironment limits the efficacy of immunotherapy in CRPC. Fatty acid-binding protein 5 (FABP5) is highly expressed in PCa; however, its role in tumor-associated immune suppression remains poorly defined. This study investigated the effects of FABP5 silencing on tumor proliferation and cluster of differentiation (CD)8+ T cell activity in PCa. FABP5-silenced RM-1 cells were co-cultured with CD8+ T cells, and tumor cell proliferation and T cell differentiation were assessed using Cell Counting Kit-8 assays, colony formation assays, and flow cytometry. In vivo tumor-bearing mouse models were established to evaluate the effect of FABP5 silencing on tumor growth and CD8+ T cell differentiation. Enzyme-linked immunosorbent assays and western blotting were used to analyze cytokine production and protein expression in cells and tumor tissues. Silencing FABP5 significantly reduced RM-1 cell viability and enhanced CD8+ T-cell cytotoxic activity, as evidenced by increased proportions of interferon gamma (IFN-γ)+, CD107a+, and tumor necrosis factor (TNF)-α+ CD8+ T cells, along with elevated secretion of IFN-γ, perforin, and granzyme B. These effects were accompanied by decreased levels of prostaglandin E2 (PGE2) and microsomal prostaglandin E synthase-1 (mPGES-1). In vivo, FABP5 depletion suppressed tumor growth, promoted CD8+ T cell differentiation, and reduced PGE2, mPGES-1, PD-L1, and PCNA expression in tumor tissues. Collectively, these findings demonstrate that FABP5 depletion inhibits PCa proliferation and alleviates immune suppression by activating CD8+ T cells, highlighting FABP5 as a potential therapeutic target for CRPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China. Electronic address: Songjun2812@163.com.
- School of Medicine, Hangzhou City University, Hangzhou, China.
- Department of Nursing, Hangzhou Maternal and Child Health Care Hospital, Hangzhou, China.
- Department of Urology, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Surgery, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Zitieren
APA
Song, J., Tang, J., Cai, J., Wu, Y., Chen, Z., Wu, Y., & Zhai, D. (2026). Silencing fatty acid binding protein 5 inhibits prostaglandin E2 and activates CD8 T cells in castration-resistant prostate cancer. Reproductive Biology, 26(2), 101187. https://doi.org/10.1016/j.repbio.2026.101187
Vancouver
Song J, Tang J, Cai J, Wu Y, Chen Z, Wu Y, et al. Silencing fatty acid binding protein 5 inhibits prostaglandin E2 and activates CD8 T cells in castration-resistant prostate cancer. Reproductive Biology. 2026;26(2):101187. doi:10.1016/j.repbio.2026.101187
BibTeX
@article{Song2026,
author = {Song, Jun and Tang, Jiayu and Cai, Jun and Wu, Ye and Chen, Zhongming and Wu, Yaokan and Zhai, Dong},
title = {Silencing fatty acid binding protein 5 inhibits prostaglandin E2 and activates CD8 T cells in castration-resistant prostate cancer},
journal = {Reproductive Biology},
year = {2026},
volume = {26},
number = {2},
pages = {101187},
doi = {10.1016/j.repbio.2026.101187}
}
EUVIMED